Cargando…
Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infection
Respiratory Syncytial Virus (RSV) infects almost all children under the age of one and is the leading cause of hospitalization among infants. Despite several decades of research with dozens of candidate vaccines being vigorously evaluated in pre-clinical and clinical studies, there is no licensed va...
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226510/ https://www.ncbi.nlm.nih.gov/pubmed/30413743 http://dx.doi.org/10.1038/s41598-018-34999-z |